Waterdrop Inc. Q1 2026 Earnings
Analysis based on 7 articles · First reported Jun 16, 2026 · Last updated Jun 16, 2026
The strong financial performance of Waterdrop Inc., including significant revenue growth and sustained profitability, is expected to positively impact its stock price and investor confidence. The company's continued investment in AI and expansion of its healthcare services also signals future growth potential, attracting further market attention to the technology and healthcare sectors in China. The share repurchase program also signals confidence in the company's valuation.
Waterdrop Inc. announced its unaudited financial results for the first quarter ended March 31, 2026, reporting a net operating revenue of RMB1,242.2 million, a 64.8% year-over-year increase, and a net profit of RMB98.4 million, marking its 17th consecutive quarter of profitability. The company also repurchased approximately 61.8 million American Depositary Shares. Waterdrop Inc. is celebrating its tenth anniversary and is committed to advancing AI-powered technology in its insurance and healthcare services. Its insurance-related income grew by 74.1% year-over-year, with AI integration driving premium increases. The Waterdrop Medical Crowdfunding platform has facilitated RMB73.5 billion in donations for 3.75 million patients. The E-Find Platform, its digital clinical trial solutions business, generated RMB24.2 million in revenue and partnered with 243 pharmaceutical companies and CROs. Waterdrop Inc. also engaged in social responsibility initiatives, partnering with the China — Jinyun County Medical Insurance Bureau to enhance healthcare security.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard